What are the indications for Lynparza (Lipdroxy)?

Olaparib (Olaparib), as a precise and potent poly(ADP-ribose) polymerase (PARP) inhibitor, has a significant inhibitory effect on PARP1 and PARP2 enzymes. PARP inhibitors are a new direction in anti-cancer treatment. They exploit the DNA repair weaknesses of BRCA-mutated cancer cells and further destroy their repair systems, thus triggering the death of cancer cells, providing new possibilities for anti-cancer treatment.

Lynparza, alone or in combination with bevacizumab (Avastin), may help maintain the response of certain types of cancer of the ovaries (the female reproductive organs that form eggs), fallopian tubes (the tubes that carry eggs released from the ovaries to the uterus), and peritoneum (the layer of tissue in the abdomen) in people who have responded completely or partially to first or subsequent chemotherapy. Olapar is also used to treat certain types of cancer that have spread to other parts of the body, do not improve, or get worse after treatment with other therapies. It is also used to treat certain types of early-stage cancer in patients who have already undergone surgery and other chemotherapy treatments. Lynparza is also used to treat a certain type of prostate cancer that has spread to other parts of the body, is no longer responding to drugs or surgical treatments that lower testosterone levels, and has progressed after treatment with enzalutamide (Xtandi) or abiraterone (Yonsa, Zytiga). It is also used in combination with abiraterone and prednisone to treat a certain type of prostate cancer that has spread to other parts of the body and no longer responds to medical or surgical treatments that lower testosterone levels. Lynparza is also used to help maintain the response of certain types of cancer that do not spread or progress after the first dose of chemotherapy.

Lynparza is available as tablets to be taken by mouth twice daily with or without food. Try to space your doses about 12 hours apart. Take Lynparza at about the same time each day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any parts you don't understand. Take Lynparza exactly as directed. Do not take more, less, or more often than prescribed by your doctor.

Olaparib is now on the market in my country and can be reimbursed by medical insurance. In the Chinese market, the original version of Lynparza has a tablet size of 150 mg and 56 tablets. The price after medical insurance reimbursement is about 4,500 yuan, but it is best to consult the local hospital for the specific price. In addition, overseas, there are a variety of generic versions of Lynparza on the market, including capsules and tablets. The overseas generic version of Lynparza capsules has 50 mg and 112 capsules per bottle, and the price is about 1,600-1,800 yuan; while the generic tablet version is 150 mg*120 capsules, and the price is between 2,000 and 5,700 yuan.